Sarepta Therapeutics (SRPT) has the following price history information. Looking back at SRPT historical stock prices for the last five trading days, on April 12, 2024, SRPT opened at $124.17, traded as high as $124.82 and as low as $121.49, and closed at $122.87. Trading volume was a total of 656.10K shares. On April 15, 2024, SRPT opened at $122.18, traded as high as $122.99 and as low as $117.78, and closed at $118.31. Trading volume was a total of 860.40K shares. On April 16, 2024, SRPT opened at $117.60, traded as high as $118.69 and as low as $116.94, and closed at $117.29. Trading volume was a total of 592.90K shares. On April 17, 2024, SRPT opened at $117.00, traded as high as $119.08 and as low as $115.93, and closed at $117.89. Trading volume was a total of 546.10K shares. On April 18, 2024, SRPT opened at $117.55, traded as high as $118.90 and as low as $115.79, and closed at $116.55. Trading volume was a total of 498.60K shares.

SRPT Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sarepta Therapeutics shares, starting with a $10,000 purchase of SRPT, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/22/2014
End date:	04/18/2024
Start price/share:	$38.79
End price/share:	$116.55
Dividends collected/share:	$0.00
Total return:	200.46%
Average Annual Total Return:	11.63%
Starting investment:	$10,000.00
Ending investment:	$30,038.51
Years:	10.00

SRPT Historical Price Range
Date	Open	High	Low	Close	Volume
04/12/2024	$124.17	$124.82	$121.49	$122.87	656.10K
04/15/2024	$122.18	$122.99	$117.78	$118.31	860.40K
04/16/2024	$117.60	$118.69	$116.94	$117.29	592.90K
04/17/2024	$117.00	$119.08	$115.93	$117.89	546.10K
04/18/2024	$117.55	$118.90	$115.79	$116.55	498.60K

About Sarepta Therapeutics

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.

SRPT Historical Closing Prices
Date	Close
04/12/2024	$122.87
04/15/2024	$118.31
04/16/2024	$117.29
04/17/2024	$117.89
04/18/2024	$116.55

Healthcare Historical Prices

SRPT is categorized under the Healthcare sector; below are some other companies in the same sector: SRRA Historical Stock Prices SRTS Historical Stock Prices SSH Historical Stock Prices SSKN Historical Stock Prices SSRG Historical Stock Prices SSY Historical Stock Prices STAA Historical Stock Prices STE Historical Stock Prices STEM Historical Stock Prices STJ Historical Stock Prices Also explore: SRPT shares outstanding history Free SRPT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

SRPT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.